Physicians' awareness of medication-related osteonecrosis of the jaw in patients with osteoporosis.
A serious adverse effect of antiresorptive drugs, which are widely used to treat osteoporosis, is medication-related osteonecrosis of the jaw (MRONJ). Physicians can reduce the risk of MRONJ by educating patients and emphasizing the importance of good oral health. However, limited information is ava...
Saved in:
| Main Authors: | Nachapol Supanumpar, Pagaporn Pantuwadee Pisarnturakit, Natthinee Charatcharoenwitthaya, Keskanya Subbalekha |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0297500&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient Perspective on Dental Care Amidst COVID-19 Pandemic: A Survey During Omicron Stage
by: Paratcha Pingsuthiwong DDS, MSc, et al.
Published: (2025-05-01) -
Dental Hygienists’ Awareness of Medication-Related Osteonecrosis of the Jaw in Private Dental Clinics in Japan
by: Yosuke Iijima DDS, PhD, et al.
Published: (2024-10-01) -
Validation of the Thai short form of the Attitudes to Ageing Questionnaire.
by: Nattapat Khongsirisombat, et al.
Published: (2025-01-01) -
Panoramic Radiography Features of Medication-Related Osteonecrosis of the Jaws (MRONJ)
by: Rossana Izzetti, et al.
Published: (2023-01-01) -
Bisphosphonate-related osteonecrosis of the jaw: An enigma among medical practitioners
by: Shalini Krishnan, et al.
Published: (2019-01-01)